Lipoprotein Size and Susceptibility to Atherosclerosis — Insights from Genetically Modified Mouse Models

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|3|174-189

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.3, 2008-03, pp. : 174-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Applications and Limitations of Genetically Modified Mouse Models in Drug Discovery and Development

By  

Current Drug Metabolism, Vol. 9, Iss. 5, 2008-06 ,pp. : 419-438

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis and Efferocytosis in Mouse Models of Atherosclerosis

By  

Current Drug Targets, Vol. 8, Iss. 12, 2007-12 ,pp. : 1288-1296

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

By  

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 603-612

Bentham Science Publishers

Access to resources Recommend Favorite

Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models

By Rivera Jennifer   Sobey Christopher G.   Walduck Anna K.   Drummond Grant R.  

Redox Report, Vol. 15, Iss. 2, 2010-04 ,pp. : 50-63

Maney Publishing

Access to resources Recommend Favorite

Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 429-438

Bentham Science Publishers

Access to resources Recommend Favorite